PMID: 42410Dec 1, 1979

A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus

Arthritis and Rheumatism
J H KlippelG Schiffman

Abstract

The immunogenicity and potential for disease modification of pneumococcal polysaccharide vaccine in systemic lupus erythematosus were evaluated in a controlled, double-blind study. Forty patients were randomly chosen to receive an intramuscular injection of either vaccine or placebo. Changes in mean antibody concentrations (nanograms antibody nitrogen per milliliter serum) to 12 type-specific pneumococcal capsular antigens from prevaccination to one month after vaccination were 177 to 1045 in the vaccine (P less than 0.001) and 164 to 153 in the placebo-treated patients. In the month after vaccination, neither vaccine nor placebo-treated patients had a significant change in lupus disease activity as assessed by a composite clinical, laboratory, and serologic index. We conclude that patients with systemic lupus erythematosus can be successfully immunized with pneumococcal vaccine without detectable alterations of the underlying disease.

References

Oct 27, 1977·The New England Journal of Medicine·R Austrian
Aug 31, 1978·The New England Journal of Medicine·G R SiberG Schiffman
Jul 5, 1979·The New England Journal of Medicine·V I AhonkhaiG Schiffman
Jan 28, 1978·Lancet·J L SullivanR J Wedgwood
Jun 1, 1978·Annals of Internal Medicine·R BrodmanP H Schur
Jun 1, 1978·Annals of Internal Medicine·G W WilliamsR Dolin
Jun 1, 1978·Annals of Internal Medicine·E V Hess, V Hahn
Jul 1, 1979·Arthritis and Rheumatism·J KarshJ L Decker
Jun 1, 1978·Annals of Internal Medicine·S C RistowJ J Condemi
Feb 1, 1976·The American Journal of Medicine·M B UrowitzM A Ogryzlo
Jan 1, 1974·Arthritis and Rheumatism·P J StaplesR S Gordon
Apr 1, 1969·The Journal of Clinical Investigation·J Baum, M Ziff
Mar 1, 1961·Proceedings of the Society for Experimental Biology and Medicine·L H MUSCHEL
Oct 14, 1948·The New England Journal of Medicine·L F AYVAZIAN, T L BADGER

Citations

Oct 20, 1998·Arthritis and Rheumatism·D F BattafaranoR J Enzenauer
Nov 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G A Bruyn, R van Furth
Feb 13, 2007·Zeitschrift für Rheumatologie·A Rubbert-Roth
Dec 4, 2010·Zeitschrift für Rheumatologie·D Meyer-OlsonR E Schmidt
Aug 10, 2013·Zeitschrift für Rheumatologie·S GoldackerKommission Pharmakotherapie der DGRh
Aug 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C G WhitneyJ C Butler
Dec 12, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ori ElkayamJeffrey B Rubins
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T Glück, Ulf Müller-Ladner
Apr 1, 1989·Annals of the Rheumatic Diseases·D Petros, S West
Feb 24, 2016·La Revue de médecine interne·A Mathianle groupe France lupus érythémateux systémique réseau (FLEUR) et les centres de référence et de compétence des lupus et synd
Jan 30, 2014·International Reviews of Immunology·Tiffany CazaAndras Perl
Jun 5, 2010·International Reviews of Immunology·Simonetta Salemi, Raffaele D'Amelio
Jun 5, 2010·International Reviews of Immunology·Simonetta Salemi, Raffaele D'Amelio
Sep 27, 2015·Translational Research : the Journal of Laboratory and Clinical Medicine·John E McKinnon, Kathleen Maksimowicz-McKinnon
Dec 1, 1990·Seminars in Arthritis and Rheumatism·S R MitchellP Katz
Jun 15, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yoshiki KurodaMinoru Satoh
Feb 1, 1994·Rheumatic Diseases Clinics of North America·P H White
Sep 1, 1999·Rheumatic Diseases Clinics of North America·R K Avery
Jun 4, 2002·Best Practice & Research. Clinical Rheumatology·Barri J Fessler
Aug 14, 2008·Autoimmunity Reviews·Fabrizio ContiGuido Valesini
Dec 10, 2014·Nature Reviews. Rheumatology·Johanna WestraMarc Bijl
Nov 12, 2016·The Journal of Allergy and Clinical Immunology. in Practice·Ali Sobh, Francisco A Bonilla
Jul 13, 2001·Infectious Disease Clinics of North America·E BouzaP Muñoz
Apr 24, 2001·Lupus·A Aron-Maor, Yehuda Shoenfeld
Nov 1, 1980·Arthritis and Rheumatism·A Adunsky, J Bernheim
Oct 24, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rama D YammaniKaren M Haas
Jul 28, 2017·Expert Review of Clinical Immunology·Nicola Luigi BragazziYehuda Shoenfeld
Nov 1, 1980·Arthritis and Rheumatism·M P JarrettA I Grayzel
Sep 11, 1986·The New England Journal of Medicine·C Van der Straeten, J H Klippel
Jul 1, 1988·Arthritis and Rheumatism·M H LiangJ M Esdaile

Related Concepts

Adrenal Cortex Hormones
Anti-Inflammatory Agents
Antibodies, Bacterial
Antimalarials
Bacterial Vaccines
Polychemotherapy
Lupus Erythematosus, Systemic
Polysaccharides
Streptococcus pneumoniae

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.